EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Rapid Diagnosis of Intrahepatic Cholestasis of Pregnancy (ICP): Validation of an Automated Enzymatic Total Bile Acid Assay and Assessment of Ursodeoxycholic Acid Impact on Bile Acid Profiles in an ICP Cohort

Jillian Kodger, Haleh Nadim, Ibrahim Choucair, Angela Sutphin, Tore Eid, Joe M El-Khoury

The Journal of Applied Laboratory Medicine · 2026-11-04 · 11 (6) · 1442-1451

DOI: 10.1093/jalm/jfag099 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Intrahepatic cholestasis of pregnancy (ICP) requires timely diagnosis to guide management, including initiation of ursodeoxycholic acid (UDCA) and delivery planning. LC-MS/MS provides fractionated bile acid profiles but has a turnaround time (TAT) of approximately 1 week, delaying treatment. Enzymatic total bile acid (TBA) assays offer faster results but measure all bile acids collectively, which some have reported can be impacted by UDCA treatment. Methods We validated the Diazyme enzymatic TBA assay on a Roche Cobas analyzer, assessing analytical measurement range, reference interval, precision, and accuracy vs LC-MS/MS. The comparison cohort included samples from 100 pregnant patients (median age 31 years; gestational age 34 weeks) presenting with pruritus and suspected of ICP. A secondary analysis examined UDCA and tauroursodeoxycholic acid in a UDCA-detectable subset. TAT was evaluated retrospectively in 971 specimens. Results We verified the assay’s analytical measurement range of 1 to 180 µmol/L and reference interval of <10 µmol/L. Precision was <10%, and method comparison revealed minimal bias, with 98% clinical concordance. In the UDCA subset (n = 19), UDCA and tauroursodeoxycholic acid represented minor fractions of total TBA. Operationally, the enzymatic assay provided rapid results, with a median TAT of 5.6 h from collection (range 0.6–36.8) and 0.5 h from receipt (range 0.2–22.3); delays were mainly due to transport. Conclusions The Diazyme enzymatic TBA assay on Roche Cobas demonstrates robust performance and rapid turnaround, supporting timely ICP diagnosis and management. LC-MS/MS remains useful for fractionated profiling but is limited by longer TAT.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →